Pharmacies in Kew, VIC
Find accurate info on the best pharmacies in Kew. Get reviews and contact details for each business, including phone number, address, opening hours, promotions and other information.
Showing results: 1 - 7 out of 7
Showing results: 1 - 7 out of 7
Results from the 'Pharmacies' category in Kew
Closed now
157 High St, Kew, 3101
(03) 9852 9888
Pharmacy, pharmacies & drugstores 
Closed now
1/101 Willsmere Rd, Kew, 3101
(03) 9853 9058
drugs, prescription, chemists retail pharmacies, Pharmacies, pharmacists, dispensing chemist, chemists, health, pharmacy, over the counter drugs 
Closed now
120 Cotham Rd, Kew, 3101
(03) 9994 8028
Edge compounding is a pharmacy specialised in human and veterinary compounding and customised pharmacist formulated skincare and cosmeceutical solutions. Our compounding specialities include men, women and children health, veterinary, dermatology, pain management, weight management, hair loss, sleeping aids and bioidentical natural hormone replacement therapy (HRT). 
89 High Street, Kew, 3101
(03) 9853 5134
Prescient Therapeutics is an Australian based, clinical stage oncology company committed to developing and commercialising novel products that have great potential to improve standard cancer treatments around the world. Listed on the Australian Stock Exchange (ASX), the company holds an exclusive worldwide license to the highly promising cancer compound GGTI-2418 for the treatment of multiple myeloma, breast and pancreatic cancer. GGTI-2418 is expected to enter Phase 1b/2 clinical trials in breast cancer and myeloma in early 2015. In addition, Prescient has recently acquired US oncology company AKTivate Therapeutics and its novel TCN-P cancer drug - a second and equally promising novel drug candidate. TCN-P is currently in two active clinical trials - a Phase 1b/2 in breast cancer and an active Phase 1b in ovarian cancer. These trials are funded by US government authorities including grants from the Department of Defense and National Cancer Institute. Prescient’s portfolio also includes a third platform - the Co-X-Gene technology. The Company has granted a license to major French biotechnology company Transgene for access to this Co-X-Gene technology for use in two of Transgene’s immunotherapeutic products. 
17 Cotham Road, Kew, 3101
0498 010 299
DIFICID (fidaxomicin) is a new therapy to treat Clostridium difficile (C. difficile) infection, a hospital infection resistant to multiple antibiotics. 